找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Handbook of Chronic Myeloid Leukemia; Timothy P Hughes,David M Ross,Junia V Melo Book 2014 Springer International Publishing Switzerland 2

[复制链接]
楼主: 小费
发表于 2025-3-23 10:16:30 | 显示全部楼层
Introduction,Chronic myeloid leukemia (CML) is a myeloproliferative disease of the hematopoietic stem cell (HSC). In its natural history, CML is a tri-phasic disease, presenting predominantly in a chronic phase averaging around 5–7 years, but spanning from between a few months to over 20 years.
发表于 2025-3-23 15:47:00 | 显示全部楼层
Diagnosis,When a patient presents with suspected chronic myeloid leukemia (CML) appropriate assessments are needed to confirm the diagnosis and stage of disease, and to assign a risk score to that patient.
发表于 2025-3-23 20:52:35 | 显示全部楼层
发表于 2025-3-23 22:43:04 | 显示全部楼层
发表于 2025-3-24 03:15:17 | 显示全部楼层
发表于 2025-3-24 09:51:42 | 显示全部楼层
https://doi.org/10.1007/978-3-319-08350-6BCR-ABL signaling; Hematology; Leukemia; Tyrosine kinase inhibitors; pharmacotherapy
发表于 2025-3-24 10:40:19 | 显示全部楼层
发表于 2025-3-24 15:42:42 | 显示全部楼层
发表于 2025-3-24 19:49:40 | 显示全部楼层
发表于 2025-3-25 00:37:59 | 显示全部楼层
https://doi.org/10.1007/978-3-030-01294-6 not. Palliation with alpha interferon (IFNα) could prolong survival substantially for the 15–30 % of patients who had IFNα-responsive disease but quality of life for these patients was often markedly impaired.
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-3 18:51
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表